Lung Cancer Edition: Top Headlines for Week of April 28, 2025
In this edition, reduction efforts prevent 3.8 million lung cancer deaths since 1970, first-line combination should be ‘new standard’ in advanced lung cancer and more. Read the full coverage here: Smoking cessation, reduction efforts prevent 3.8 million lung cancer deaths since 1970 First-line combination should be ‘new standard’ in advanced lung cancer Only 1 in 5 people treated with immune checkpoint inhibitors respond to therapy ‘It can save their lives’: Annual lung cancer screening improves cancer detection rate ‘Are we giving false hope?’: Few hospitalized people with cancer benefit from immunotherapy References: Haslam A, et al. Int J Cancer. 2025;doi:10.1002/ijc.35347. Islami F, et al. CA Cancer J Clin. 2025;doi:10.3322/caac.70005. Kim RY, et al. JAMA Netw Open. 2025;doi:10.1001/jamanetworkopen.2025.0942. Riaz F, et al. JCO Oncol Pract. 2025;doi:10.1200/OP-24-00788. Yang JCH, et al. Amivantamab plus lazertinib vs osimertinib in first-line EGFR-mutant advanced NSCLC. Presented at: European Lung Cancer Congress; March 26-29, 2025; Paris.
--------
13:59
Gastroenterology Edition: Top Headlines for Week of April 14, 2025
In this edition, sick food service workers top driver of viral foodborne outbreaks in US, no weight loss benefit with semaglutide before bariatric surgery and more. Read the full coverage here: Sick food service workers remain top driver of viral foodborne outbreaks in US ‘We have work to do’: No weight loss benefit with semaglutide before bariatric surgery Mailed FIT outreach program boosts colorectal cancer screening in rural areas ‘Distinct viral exposure patterns’ found in patients with Crohn’s years before diagnosis Mortality, dropout risk higher on liver transplant waitlist in low-density areas References: Coronado GD, et al. JAMA Netw Open. 2025;doi:10.1001/jamanetworkopen.2025.0928. Holst MM, et al. MMWR Surveill Summ. 2025;doi:10.15585/mmwr.ss7401a1. Mathur V, et al. JAMA Surg. 2025;doi:10.1001/jamasurg.2025.0001. Nandy A, et al. Gastroenterology. 2025;doi:10.1053/j.gastro.2025.01.247 Tanaka T, et al. JAMA Netw Open. 2025;doi:10.1001/jamanetworkopen.2025.1759.
--------
12:01
Lung Cancer Edition: Top Headlines for Week of March 17, 2025
In this edition, recurrence-free survival estimates in less advanced lung cancer, bronchoscopy-guided microwave ablation safe in lung abnormality and more. Read the full coverage here: Recurrence-free survival estimates after surgery higher in less advanced lung cancer Electromagnetic navigation bronchoscopy-guided microwave ablation safe in lung abnormality High prevalence of atherosclerosis detected in patients entering lung cancer therapy Wood dust exposure negatively impacts lung function in carpenters 40% of people treated with chemotherapy develop persistent, severe nerve pain References: D'Souza RS, et al. Reg Anesth Pain Med. 2025;doi:10.1136/rapm-2024-106229. Elfatih NM, et al. BMC Pulm Med. 2025;doi:10.1186/s12890-025-03535-x. Malozzi C. Implementation science (application of research into practice/policy). Presented at: American College of Cardiology’s Advancing the Cardiovascular Care of the Oncology Patient course; Feb. 14-16, 2025; Washington, D.C. Rajaram R, et al. CHEST. 2023;doi:10.1016/j.chest.2023.11.042. Wang S, et al. J Thorac Dis. 2024;doi:10.21037/jtd-24-1052.
--------
12:20
Lung Cancer Edition: Top Headlines for Week of February 17, 2025
In this edition, robotic-assisted bronchoscopy a ‘game changer’, global mortality related to tobacco drops, particulate matter rises and more. Read the full coverage here: Robotic-assisted bronchoscopy a ‘game changer’ in early diagnosis of lung cancer Global lung cancer mortality related to tobacco drops, particulate matter rises in 2019 Osimertinib linked to more therapy-related cardiac events than other TKIs for NSCLC Survival better with lobectomy vs. wedge resection in early stage lung cancer Zenocutuzumab exhibits efficacy in NRG1 fusion-positive cancers References: Expert Submission Jani CT, et al. eClinicalMedicine. 2025;doi:10.1016/j.eclinm.2024.103033. Lin CY, et al. JAMA Netw Open. 2024;doi:10.1001/jamanetworkopen.2024.48364. Schram AM, et al. N Engl J Med. 2025;doi:10.1056/NEJMoa2405008. Seder C. Anatomic lung resection is associated with improved survival compared with wedge resection for stage IA non-small cell lung cancer. Presented at: 2025 Society of Thoracic Surgeons Annual Meeting; Jan. 24-26; Los Angeles.
--------
13:36
Lung Cancer Edition: Top Headlines for Week of January 20, 2025
In this edition, combination extends survival vs. standard first-line therapy, integrated care for smoking cessation during lung cancer screening and more. Read the full coverage here: Combination extends survival vs. standard first-line therapy for advanced lung cancer Integrated care ‘best treatment option’ for smoking cessation during lung cancer screening FDA proposes cap on nicotine levels in cigarettes Global lifetime risk for lung cancer in 2022 differs by human development index, sex FDA grants priority review to oral non-small cell lung cancer drug References: Cinciripini P, et al. JAMA Intern Med. 2024;doi:10.1001/jamainternmed.2024.7288. Li M, et al. Chin Med J (Engl). 2024;doi:10.1097/CM9.0000000000003368. Press Release Press Release Press Release
UK